Elevance Health, Inc. (ELV)
Data as of , from SEC Form 4 filings.
See up to 3 months of ELV. The 7-day demo opens the 1M and 3M ranges and puts ELV on your watchlist.
Start 7-day demoLatest ELV insider trades
- Ramiro G. Peru - DirectorOpen-market purchase$366K
Gail Boudreaux - OfficerOpen-market purchase$249K
About Elevance Health, Inc. (ELV)
Elevance Health, Inc. is an SEC registrant, filing under CIK 0001156039, classified as hospital and medical service plans. We track it alongside the rest of the Health Care sector.
ELV Form 4 activity by transaction type, last 90 days
| Form 4 transaction type | Transactions | Shares | Total value |
|---|---|---|---|
| Open-market purchase | 3 | 3,725 | $1.37M |
| Grant or award | 1 | 2,627 | |
| Tax withholding / forfeiture | 4 | 4,654 |
Dollar totals cover purchases and sales only (codes P and S). Grants, option exercises, gifts and tax withholding are counted in shares, because none of them is a trade at a market price.
ELV insider transactions (Form 4)
2953 Form 4 filings on record, the earliest from Oct 4, 2024, newest first. Filing history page 2 of 2.
| Date | Insider | Transaction | Security | Shares | Price | Value |
|---|---|---|---|---|---|---|
| Amy W. Schulman - Director | Grant or award | Common Stock | 218 footnote F1,F2 | $0.00 | - | |
| ||||||
| Ryan R. Craig - Officer | Tax withholding / forfeiture | Common Stock | 279 footnote F1 | $341.83 | $95K | |
| ||||||
| Mark Kaye - Officer | Tax withholding / forfeiture | Common Stock | 2,895 footnote F1 | $340.24 | $985K | |
| ||||||
| Erin M. Wessling - Officer | Tax withholding / forfeiture | Common Stock | 152 | $321.59 | $49K | |
| Erin M. Wessling - Officer | Grant or award | Common Stock | 931 | $0.00 | - | |
| Erin M. Wessling - Officer | Grant or award | Employee Stock Option (Right to Buy) | 3,541 | $0.00 | - | |
| Ryan R. Craig - Officer | Grant or award | Common Stock | 970 | $0.00 | - | |
| Ryan R. Craig - Officer | Grant or award | Employee Stock Option (Right to Buy) | 3,690 | $0.00 | - | |
 Susan D. Devore - Director | Open-market purchase | Common Stock | 1,200 | $312.15 | $375K | |
| Steven H. Collis - Director | Grant or award | Common Stock | 639 | $0.00 | - | |
| Gail Boudreaux - Officer | Open-market purchase | Common Stock | 2,334 | $286.07 | $668K | |
| Gail Boudreaux - Officer | Open-market purchase | Common Stock | 5,116 | $287.12 | $1.47M | |
| Gail Boudreaux - Officer | Open-market purchase | Common Stock | 1,050 | $287.96 | $302K | |
 Deanna D. Strable-Soethout - Director | Grant or award | Common Stock | 601 | $0.00 | - | |
| Ryan M. Schneider - Director | Grant or award | Common Stock | 601 | $0.00 | - | |
| Ramiro G. Peru - Director | Grant or award | Common Stock | 601 | $0.00 | - | |
| Antonio F. Neri - Director | Grant or award | Common Stock | 601 | $0.00 | - | |
| Bahija Jallal - Director | Grant or award | Common Stock | 601 | $0.00 | - | |
| Lewis Hay III - Director | Grant or award | Common Stock | 601 | $0.00 | - | |
| Robert L. Dixon Jr. - Director | Grant or award | Common Stock | 601 | $0.00 | - | |
| Susan D. Devore - Director | Grant or award | Common Stock | 601 | $0.00 | - | |
| R. Kerry Clark - Director | Grant or award | Common Stock | 601 | $0.00 | - | |
| Mark Kaye - Officer | Open-market sale | Common Stock | 4,588 | $424.82 | $1.95M | |
| Charles Morgan Kendrick Jr. - Officer | Tax withholding / forfeiture | Common Stock | 846 | $414.01 | $350K | |
| Charles Morgan Kendrick Jr. - Officer | Grant or award | Common Stock | 1,710 | $0.00 | - | |
| Peter D. Haytaian - Officer | Tax withholding / forfeiture | Common Stock | 1,649 | $414.01 | $683K | |
| Peter D. Haytaian - Officer | Grant or award | Common Stock | 3,799 | $0.00 | - | |
| Charles Morgan Kendrick Jr. - Officer | Open-market sale | Common Stock | 7,417 | $432.14 | $3.21M | |
| Mark Kaye - Officer | Tax withholding / forfeiture | Common Stock | 2,818 | $505.16 | $1.42M | |
Recent ELV Form 144 notices of proposed sale
3An insider files Form 144 before selling restricted or control stock. It announces a planned sale. If the sale goes ahead, it shows up later on a Form 4.
| Filed | Filer | Relationship | Shares | Market value | Notice |
|---|---|---|---|---|---|
| - | - | - | - | View on EDGAR | |
| - | - | - | - |
ELV insider trading FAQ
What is the latest insider trade for ELV?
Elevance Health, Inc. (ELV) had 5 insider filings in the last 90 days, with the most recent on 2026-10-06. The full record for ELV runs to 53 Form 4 filings, the earliest from 2024-10-04. InsiderAlpha adds new Form 4, Form 144 and 8-K filings as they arrive from SEC EDGAR.
How many insiders are buying ELV stock?
3 insider purchases of ELV were filed in the last 90 days, totaling $1.37M.
How many insiders are selling ELV stock?
No insider sales of ELV were filed in the last 90 days. 7 sales are on record for this company.
Where can I see ELV SEC filings (Form 4, 10-K, 10-Q, 8-K)?
This page collects ELV Form 4 insider transactions, Form 144 sale notices and 8-K filings in one place. Annual 10-K and quarterly 10-Q reports live on the company's SEC EDGAR page.
More Health Care companies with insider activity
Recent insider filings
10The EDGAR links open each original Form 4, so you can check any number on this page against the filing it came from.
- - Mark Kaye view on EDGAR
- - Erin M. Wessling view on EDGAR
- - Ryan R. Craig view on EDGAR
- - Ramiro G. Peru view on EDGAR
- - Gail Boudreaux view on EDGAR
- - Ronald W. Penczek view on EDGAR
- - Robert L. Dixon Jr. view on EDGAR
- - Ronald W. Penczek view on EDGAR
- - Deanna D. Strable-Soethout view on EDGAR
Related companies with recent insider activity
Learn more
- How to read insider buying signals
- What an open-market purchase by an insider can and cannot tell you.
- Form 144 vs Form 4
- A Form 144 announces a planned sale; the Form 4 reports it after it happens.
- Insider activity in Health Care
- Where ELV's peers are being bought and sold.
- Every recent Form 4
- The market-wide feed, updated as filings arrive from SEC EDGAR.
Follow ELV with a 7-day demo
- ELV on your watchlist
- Every ELV Form 4 filing on record
- Up to 3 months of ELV price history
- The daily trading plan of ranked insider buys, on a delay, with the plan archive
